Lise Aagaard

Junior Associate

About Lise Aagaard

PhD (pharm.) 2008
Master of Laws (University of Copenhagen) 2015
Master of Science in Pharmacy (Msc Pharm.) 2001

English, German

Lise Aagaard specialises in life sciences, including regulatory science, medico, clinical tests, market access and pharmacovigilance.

As professor of clinical pharmacy at the University of Southern Denmark, Lise primarily focuses on drug safety policies, including particularly use of pharmaceuticals by minors.

Previously, Lise was associate professor of community pharmacy at the University of Copenhagen, monitoring drug safety and clinical tests for the Danish Medicines Agency and designing the national interaction database and quality control at H. Lundbeck A/S.

Lise Aagaard was former member of the research council of Odense University Hospital and Chair of board of the Danish Pharmaceutical Society.


  • Editor in chief: Orphan Drugs - Research and Reviews (Dove Press NZ
  • Review editor - Frontiers in Medicine (Frontiers Schweizerland)


  • Knowledge creation about adverse drug reactions. Analysis of data from pre-and post-marketing files
    Københavns Universitet, Det Farmaceutiske Fakultet, 2008, Report
  • Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance
    Int J Obes (Lond). , 2016, Article
  • Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012
    Eur Neuropsychopharmacol, 2016, Article
  • Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™
    Drug Saf., 2012, Article
  • The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies
    Neuropsychiatr Dis Treat, 2011, Article
  • Using text-mining techniques in electronic patient records to identify ADRs from medicine use
    Br J Clin Pharmacol. , 2012, Article
  • Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions
    Br J Clin Pharmacol., 2011, Article
  • Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007
    Drug Saf. , 2010, Article
  • Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006
    Drug Saf., 2009, Article
  • Opening the white boxes: the licensing documentation of efficacy and safety of psychotropic medicines for children
    Pharmacoepidemiol Drug Saf. , 2009, Article
  • Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector?
    Br J Clin Pharmacol., 2008, Article
  • Trends in ADHD medication use in children and adolescents in five western countries
    5. Edition, Eur Neuropsychopharmacol, 2017, Book
  • A multi-national comparison of antipsychotic drug use in children and adolescents 2005–2012
    Child and Adolescent Psychiatry and Mental Health , 2017, Article
  • Specific genes associated with paediatric adverse events from methylphenidate use: a systematic review of empirical studies
    J Res Pharm Pract , 2017, Article
  • International trends in clozapine use: A study in 17 countries, 2005-2014
    136. Edition, Acta Psychiatr Scand., 2017, Article
  • Dipeptidyl peptidase-4 inhibitor induced angioedema – an overlooked potentially lethal adverse drug reaction.
    Curr Diabetes Rev , 2017, Article
  • An international study in 16 countries, 2005 – 2014
    10. Edition, Eur Neuropsychopharmacol., 2017, Article
  • Copenhagen

    Langelinie Allé 35
    2100 Copenhagen

  • Aarhus

    Værkmestergade 2
    8000 Aarhus C

  • Shanghai Representative Office

    No.1440 Yan'an Middle Road, Suite 2H08
    Jing'an District, 200040 Shanghai, P.R. China

  • Bech-Bruun Law Firm P/S

    P +45 72270000
    F +45 72270027
    VAT number 38 53 80 71
    Cookie policy
    Legal Notice and Disclaimer
    Privacy Policy